UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$615M |
| 3 |
Sempra
SRE
|
+$496M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$438M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$353M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$514M |
| 2 |
Mondelez International
MDLZ
|
+$421M |
| 3 |
Cencora
COR
|
+$225M |
| 4 |
Invesco
IVZ
|
+$212M |
| 5 |
MON
Monsanto Co
MON
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.74% |
| 2 | Financials | 7.28% |
| 3 | Healthcare | 6.05% |
| 4 | Consumer Discretionary | 5.36% |
| 5 | Energy | 4.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
WisdomTree Global High Dividend Fund
DEW
$155M
| $1.16M | ﹤0.01% |
25,404
+1,333
| +6% | +$62.4K |
|
|
CDK
3627
PUT
DELISTED
CDK Global, Inc.
CDK
| $1.16M | ﹤0.01% |
+17,900
| New | +$1.16M |
|
3628
CALL
Humana
HUM
$46.2B
| $1.16M | ﹤0.01% |
3,900
-146,700
| -97% | -$43M |
|
3629
abrdn Physical Palladium Shares ETF
PALL
$667M
| $1.16M | ﹤0.01% |
64,095
-51,375
| -44% | -$956K |
|
|
TSRO
3630
DELISTED
TESARO, Inc.
TSRO
| $1.16M | ﹤0.01% |
26,117
-165,020
| -86% | -$8.02M |
|
3631
Verastem
VSTM
$592M
| $1.16M | ﹤0.01% |
14,055
+886
| +7% | +$54.2K |
|
|
FMBI
3632
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $1.16M | ﹤0.01% |
45,498
+22,690
| +99% | +$580K |
|
3633
Credit Acceptance
CACC
$6.08B
| $1.16M | ﹤0.01% |
3,278
-2,235
| -41% | -$767K |
|
|
IFEU
3634
DELISTED
iShares Europe Developed Real Estate ETF
IFEU
| $1.16M | ﹤0.01% |
29,089
+1,538
| +6% | +$62.9K |
|
|
OSG
3635
Octave Specialty Group
OSG
$222M
| $1.16M | ﹤0.01% |
58,180
+2,334
| +4% | +$43.1K |
|
3636
WisdomTree Emerging Markets Corporate Bond Fund
EMCB
$98.8M
| $1.16M | ﹤0.01% |
16,709
-2,022
| -11% | -$141K |
|
3637
Primoris Services
PRIM
$4.45B
| $1.16M | ﹤0.01% |
42,434
-43,763
| -51% | -$1.16M |
|
3638
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.28B
| $1.16M | ﹤0.01% |
10,015
+3,456
| +53% | +$386K |
|
|
INST
3639
DELISTED
Instructure, Inc.
INST
| $1.16M | ﹤0.01% |
27,127
+25,270
| +1,361% | +$1.07M |
|
3640
Valmont Industries
VMI
$9.53B
| $1.15M | ﹤0.01% |
7,654
-2,714
| -26% | -$397K |
|
|
ELME
3641
Elme Communities
ELME
$144M
| $1.15M | ﹤0.01% |
38,025
+4,516
| +13% | +$129K |
|
|
NTC
3642
DELISTED
Nuveen Connecticut Quality Municipal Income Fund
NTC
| $1.15M | ﹤0.01% |
96,938
-15,970
| -14% | -$187K |
|
3643
Fate Therapeutics
FATE
$326M
| $1.15M | ﹤0.01% |
101,410
+92,252
| +1,007% | +$1.02M |
|
3644
Herc Holdings
HRI
$5.61B
| $1.15M | ﹤0.01% |
20,427
+9,856
| +93% | +$575K |
|
3645
Core Laboratories
CLB
$521M
| $1.15M | ﹤0.01% |
9,105
-9,737
| -52% | -$1.19M |
|
3646
NewMarket
NEU
$8.18B
| $1.15M | ﹤0.01% |
2,838
-154
| -5% | -$60.2K |
|
3647
Oshkosh
OSK
$9.59B
| $1.15M | ﹤0.01% |
16,328
-35,294
| -68% | -$2.64M |
|
3648
White Mountains Insurance
WTM
$5.32B
| $1.15M | ﹤0.01% |
1,264
-438
| -26% | -$386K |
|
|
PDCO
3649
DELISTED
Patterson Companies, Inc.
PDCO
| $1.15M | ﹤0.01% |
50,542
+19,339
| +62% | +$436K |
|
|
EPZM
3650
DELISTED
Epizyme, Inc
EPZM
| $1.15M | ﹤0.01% |
84,503
-30,237
| -26% | -$471K |
|
Similar funds
UBS Group's Q2 2018 Portfolio in Review
As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2018 filing shows 866 new, 3,703 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
- UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
- UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
- UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
- UBS Group opened 866 new positions and closed 702 in Q2 2018.
- UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.
Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.